NSE:SUVENPHAR
Suven Pharmaceuticals Limited
- Stock
Last Close
1,137.10
02/05 08:51
Market Cap
217.41B
Beta: 1.58
Volume Today
116.13K
Avg: 310.85K
PE Ratio
38.44
PFCF: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Mar '19 | Mar '20 | Mar '21 | Mar '22 | Mar '23 | Mar '24 | Mar '25 | ||
|---|---|---|---|---|---|---|---|---|
average inventory | 1.66B - | 1.88B 13.25% | 2.42B 28.87% | 2.98B 23.06% | 2.72B 8.76% | 1.99B 26.88% | ||
average payables | 623.15M - | 769.93M 23.55% | 944.16M 22.63% | 855.33M 9.41% | 455.65M 46.73% | 612.84M 34.50% | ||
average receivables | 1.93B - | 1.75B 9.16% | 2.47B 40.78% | 2.14B 13.14% | 1.22B 42.90% | 2.09B 71.09% | ||
book value per share | 23.19 - | 33.18 43.11% | 46.39 39.78% | 59.99 29.33% | 68.18 13.64% | 80.58 18.20% | 73.13 9.25% | |
capex per share | -2.23 - | -3.91 75.07% | -4.35 11.50% | -2.95 32.17% | -11.23 280.16% | 2.04 118.12% | 6.19 204.01% | |
capex to depreciation | -4.94 - | -4.20 15.01% | -3.55 15.42% | -1.97 44.64% | -6.15 212.96% | 0.95 115.42% | 2.01 111.84% | |
capex to operating cash flow | -1.13 - | -0.24 78.79% | -0.29 20.95% | -0.23 21.19% | -0.63 178.16% | 0.14 122.79% | 0.54 274.05% | |
capex to revenue | -0.16 - | -0.12 20.54% | -0.11 8.18% | -0.06 48.47% | -0.21 265.75% | 0.05 123.10% | 0.13 163.96% | |
cash per share | 0.71 - | 1.66 135.83% | 7.38 343.17% | 20.65 180.01% | 19.14 7.31% | 32.27 68.55% | 11.54 64.24% | |
days of inventory on hand | 379.28 - | 196.63 48.16% | 174.66 11.17% | 186.36 6.70% | 195.03 4.65% | 187.40 3.92% | 199.15 6.27% | |
days payables outstanding | 129.34 - | 79.90 38.23% | 72.04 9.84% | 69.64 3.33% | 40.63 41.66% | 34.33 15.50% | 95.90 179.32% | |
days sales outstanding | 210.50 - | 78.89 62.52% | 65.52 16.94% | 89.78 37.03% | 30.26 66.29% | 46.40 53.33% | 86.81 87.08% | |
debt to assets | 0.11 - | 0.16 50.16% | 0.10 38.90% | 0.05 45.28% | 0.04 32.59% | 0.02 52.17% | 0.09 437.87% | |
debt to equity | 0.14 - | 0.22 57.16% | 0.12 45.05% | 0.06 47.50% | 0.04 36.26% | 0.02 53.60% | 0.16 774.43% | |
dividend yield | 0.01 - | 0.03 458.82% | 0.00 93.29% | 0.01 221.32% | 0.02 161.89% | |||
earnings yield | 0.03 - | 0.12 386.33% | 0.03 76.87% | 0.03 0.61% | 0.03 18.68% | 0.02 48.49% | 0.01 44.41% | |
enterprise value | 43.62B - | 27.34B 37.33% | 127.83B 367.62% | 157.96B 23.57% | 120.29B 23.85% | 170.60B 41.83% | 272.26B 59.59% | |
enterprise value over ebitda | 25.52 - | 6.18 75.77% | 25.31 309.21% | 24.73 2.28% | 19.63 20.64% | 36.47 85.85% | 62.77 72.08% | |
ev to operating cash flow | 86.54 - | 6.57 92.41% | 33.34 407.28% | 47.87 43.59% | 26.68 44.27% | 47.59 78.40% | 94.48 98.53% | |
ev to sales | 11.91 - | 3.39 71.56% | 13.04 285.07% | 12.25 6.11% | 8.97 26.72% | 16.23 80.81% | 22.73 40.10% | |
free cash flow per share | -0.25 - | 12.43 5,060.44% | 10.71 13.88% | 10.01 6.52% | 6.49 35.18% | 12.05 85.74% | 5.26 56.33% | |
free cash flow yield | -0.00 - | 0.12 8,415.92% | 0.02 82.57% | 0.02 24.91% | 0.01 15.14% | 0.02 31.02% | 0.00 72.77% | |
graham net net | 2.44 - | -2.65 208.40% | 4.97 287.72% | 23.69 376.36% | 19.51 17.66% | 32.76 67.93% | -23.99 173.24% | |
graham number | 47.32 - | 96.43 103.75% | 121.88 26.40% | 155.12 27.27% | 157.45 1.50% | 146.27 7.10% | 126.32 13.64% | |
income quality | 0.32 - | 1.03 222.06% | 0.82 20.27% | 0.49 39.71% | 0.81 62.97% | 1.19 48.19% | 0.84 29.82% | |
intangibles to total assets | 0.00 - | 0.00 30.48% | 0.00 26.31% | 0.00 30.42% | 0.03 2,488.21% | 0.03 13.16% | 0.24 763.25% | |
interest coverage | 94.86 - | 21.00 77.86% | 51.82 146.73% | 96.30 85.81% | 104.20 8.20% | 61.84 40.65% | 24.11 61.02% | |
interest debt per share | 3.32 - | 8.10 143.90% | 5.98 26.17% | 4.06 32.08% | 2.98 26.67% | 1.81 39.25% | 11.58 540.18% | |
inventory turnover | 0.96 - | 1.86 92.88% | 2.09 12.58% | 1.96 6.28% | 1.87 4.44% | 1.95 4.07% | 1.83 5.90% | |
invested capital | 0.14 - | 0.22 57.16% | 0.12 45.05% | 0.06 47.50% | 0.04 36.26% | 20.05B 49,459,647,325,220.30% | 24.92B 24.31% | |
market cap | 42.90B - | 25.59B 40.35% | 126.47B 394.21% | 157.44B 24.49% | 120.23B 23.63% | 170.42B 41.75% | 270.32B 58.62% | |
net current asset value | 1.97B - | 635.99M 67.72% | 2.71B 326.31% | 8.26B 204.48% | 7.80B 5.46% | 10.60B 35.78% | -3.03B 128.55% | |
net debt to ebitda | 0.42 - | 0.39 6.13% | 0.27 31.88% | 0.08 69.40% | 0.01 89.02% | 0.04 320.36% | 0.45 1,075.51% | |
net income per share | 4.29 - | 12.45 190.10% | 14.23 14.30% | 17.83 25.24% | 16.16 9.35% | 11.80 26.98% | 10.52 10.85% | |
operating cash flow per share | 1.98 - | 16.34 725.22% | 15.06 7.82% | 12.96 13.94% | 17.72 36.67% | 14.09 20.49% | 11.45 18.72% | |
payables turnover | 2.82 - | 4.57 61.89% | 5.07 10.91% | 5.24 3.45% | 8.98 71.40% | 10.63 18.34% | 3.81 64.20% | |
receivables turnover | 1.73 - | 4.63 166.84% | 5.57 20.40% | 4.07 27.02% | 12.06 196.67% | 7.87 34.78% | 4.20 46.55% | |
research and ddevelopement to revenue | 0.01 - | 0.01 28.85% | 0.01 20.21% | |||||
return on tangible assets | 0.14 - | 0.27 93.48% | 0.25 9.14% | 0.25 0.88% | 0.22 13.00% | 0.14 36.60% | 0.11 16.42% | |
revenue per share | 14.39 - | 31.70 120.32% | 38.49 21.44% | 50.67 31.62% | 52.66 3.94% | 41.31 21.55% | 47.58 15.17% | |
roe | 0.19 - | 0.38 102.71% | 0.31 18.23% | 0.30 3.16% | 0.24 20.23% | 0.15 38.22% | 0.16 6.58% | |
roic | 0.17 - | 0.32 89.54% | 0.28 12.82% | 0.25 9.35% | 0.23 8.23% | 0.16 29.14% | 0.08 49.31% | |
sales general and administrative to revenue | 0.02 - | 0.02 8.52% | 0.02 3.87% | 0.01 19.23% | 0.13 - | |||
shareholders equity per share | 23.19 - | 33.18 43.11% | 46.39 39.78% | 59.99 29.33% | 68.18 13.64% | 80.58 18.20% | 67.41 16.35% | |
stock based compensation to revenue | 0.00 - | 0.01 556.28% | ||||||
tangible asset value | 5.88B - | 8.42B 43.29% | 11.78B 39.94% | 15.25B 29.43% | 16.73B 9.71% | 19.89B 18.87% | 11.22B 43.60% | |
tangible book value per share | 23.08 - | 33.07 43.29% | 46.28 39.94% | 59.90 29.43% | 65.73 9.73% | 78.15 18.89% | 44.57 42.97% | |
working capital | 2.32B - | 1.91B 17.60% | 3.45B 80.39% | 9.18B 165.95% | 8.52B 7.12% | 11.56B 35.67% | 5.23B 54.73% |
All numbers in INR (except ratios and percentages)